Thesis · Proof Round ~€5M
Industrialising autonomous healthcare.
An AI-native governance layer, a public payer, and physical proof to deliver: robotics integration in Shenzhen, then a three-month field pilot in France. The opportunity in brief.
Market & margins
€500bn
Digital health market 2030
MedicalCity AI Whitepaper v2.0
€5.4bn
French APA budget · public payer
CNSA / DREES
70-75%
Target blended gross margin
~€5M
Proof Round target
Why now
Four converging curves.
AI has matured
Autonomous agents are operational.
Demographic shock
1.5 billion seniors by 2050.
Regulatory framework
GDPR, EU AI Act, APA as a universal right.
Capital is flowing
€24.5bn of VC in digital health in 2023.
Use of funds
Where the ~€5M goes.
€1.48 – 1.98M
A · Proof programme
Integration in Shenzhen, field pilot in France
≈ €3.27M
B · Scale readiness
Split on the use-of-funds ratios approved for the round
- Go-to-market & commercial ≈ €1.31M 40%
- Engineering & product ≈ €1.14M 35%
- Regulatory & compliance ≈ €490k 15%
- Working capital ≈ €196k 6%
- Legal & closing ≈ €131k 4%
Line-by-line breakdown on the Investors page — working budget, to be reconciled with signed quotes and contracts.